ZN1634 人gamma-IFN重组蛋白

人gamma-IFN的品牌是百奥莱博，是优质的重组蛋白产品，本制品用于科学研究，本品质量稳定，价位合理，需要人gamma-IFN重组蛋白等重组蛋白产品的客户，请到我公司官网联系我们。...

特别提示：包括人gamma-IFN重组蛋白在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：人gamma-IFN重组蛋白
英文名称：Recombinant Human gamma-IFN
产品货号：ZN1634
产品规格：100ng

来源：大肠杆菌
特异性：人
应用：WB 阳性对照
形态：冻干粉
纯度：>98%，RP-HPLC&SDS-PAGE
保存条件：-20℃保存 1 年以上，避免反复冻融。

根据您的关注的人gamma-IFN重组蛋白，Recombinant Human gamma-IFN，gamma-IFN，rgamma-IFN，重组gamma-IFN，您可能还对以下产品有需求：

货号	名称	规格
JN0238	重组人FGF17(成纤维细胞生长因子17)(带His标签)	10μg|50μg|500μg|1mg
JN0300	重组人趋化因子CXCL1(GROα)	10μg|50μg|500μg|1mg
JN0387	重组人白介素6受体α(IL-6Rα)	10μg|50μg|500μg|1mg
JN1950	重组人DNA聚合酶β	10μg|50μg|500μg|1mg
JN0538	重组人NCR3(天然细胞毒性触发受体3)	10μg|50μg|500μg|1mg
JN0574	重组人绒毛膜生长素(CSH1)	10μg|50μg|500μg|1mg

关注人gamma-IFN重组蛋白，Recombinant Human gamma-IFN，gamma-IFN，rgamma-IFN，重组gamma-IFN的同时，为您推荐更多您可能感兴趣的产品：



名称：重组人磷酸甘露糖变位酶2(PMM2)
货号：JN2020
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备而成，目的基因编码的Met1-Ser246在C端含有His标签。

PMM2质量控制：＞95%(还原性SDS-PAGE)

PMM2制剂：液体

PMM2保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。

关于PMM2：
Phosphomannomutase 2 (PMM2) is an enzyme that is a member of the highly variable methyltransferase superfamily. PMM2 is a cytoplasmic protein and catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate.In addition, PMM2 involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose that required for a number of critical mannosyl transfer reactions. Defects in PMM2 can results in congenital disorder of glycosylation type 1A (CDG1A). Congenital disorders of glycosylation are metabolic deficiencies in glycoprotein biosynthesis that usually cause severe mental and psychomotor retardation.

名称：重组人FcγRIIB
货号：JN0568
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Thr43-Pro217在C端含有His标签。

FcγRIIB质量控制：＞95%(还原性SDS-PAGE)

FcγRIIB制剂：冻干品

FcγRIIB保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

FcγRIIB复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于FcγRIIB：
FcγRIIB is a low affinity receptor that recognizes the Fc portion of IgG. The human CD32 group consists of FcγRIIA, FcγRIIB, and FcγRIIC proteins that share 94-99% sequence identity in their extracellular domains but differ substantially in their transmembrane and cytoplasmic domains. FcγRII protein is expressed on cells of both myeloid and lymphoid lineages as well as on cells of non-hematopoietic origin. FcγRIIB has an intrinsic cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM) and delivers an inhibitory signal upon ligand binding. Ligation of FcγRIIB on B cells down-regulates antibody production and in some circumstances may promote apoptosis. Co-ligation of FcγRIIB on dendritic cells inhibits maturation and blocks cell activation. FcγRIIB may also be a target for monoclonal antibody therapy for malignancies. FcγRIIB plays an important negative-regulating role through modulating the signals from activation receptors.

如果您觉得“ZN1634 人gamma-IFN重组蛋白”描述资料不够齐全，请联系我们获取详细资料。(联系时请告诉我从给览网看到的，我们将给您最大优惠！)
本页链接：http://www.geilan.com/com_bjbiolab/sell/itemid-8548132.html
已经有837位访客查看了本页.